Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-C-4130 | DOPE-PEG350-NH2 | DOPE-PEG-NH2,1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-amine is a active targeting drug delivery material,it can be conjugated with peptides,antibodies,or proteins which contain NHS esters, carboxy groups on the surface. | price> |
| R-M-1612 | KGF Receptor Peptide,CAS :161338-76-7 | KGF receptor peptide, which corresponds to residues 199-223 of the KGF receptor alternative exon, blocks the mitogenic activity of KGF and the interaction between KGF and its receptor. The peptide binds directly and specifically to KGF and thus represents a critical part of the KGF receptor ligand binding site. | price> |
| R-M-2095 | MC-Val-Cit-PAB-MMAE,Cas:646502-53-6 | MC-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a thio reactive maleimidocaproyl (MC) group, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. | price> |
| R-C-4131 | DOPE-polyethylene glycol550-NH2 | DOPE-PEG-NH2,1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-amine is a active targeting drug delivery material,it can be conjugated with peptides,antibodies,or proteins which contain NHS esters, carboxy groups on the surface. | price> |
| R-M-1613 | KR-12 (human),CAS :1218951-51-9 | KR-12 corresponds to amino acid residues 18-29 of LL-37 and is the smallest peptide of LL-37 retaining antibacterial activity. KR-12 displays a selective toxic effect on bacteria but not on human cells. It may be used as a template for developing novel antimicrobial agents of therapeutic use. | price> |
| R-M-2096 | Fmoc-Val-Cit-PAB-MMAE,Cas:1350456-56-2 | Fmoc-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate containing a cleavable Val-Cit peptide, a PABC linker and a MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. | price> |
| R-C-4132 | amine-PEG750-DOPE | DOPE-PEG-NH2,1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-amine is a active targeting drug delivery material,it can be conjugated with peptides,antibodies,or proteins which contain NHS esters, carboxy groups on the surface. | price> |
| R-M-1614 | Laminin A Chain (2091-2108),CAS :123063-31-0 | Peptide that supports neuron cells outgrowth and stimulates neuron-like process formation. | price> |
| R-M-2097 | Acid-PEG4-Val-Cit-PAB-MMAE | Acid-PEG4-Val-Cit-PAB-MMAE can be used antibody drug conjugation as a precursor. It contains a PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PAB linker and an MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. | price> |
| R-C-4133 | DOPE-PEG350-MAL | 1,2-Dioleoyl-sn–glycero-3-phosphoethanolamine (DOPE)-polyethylene glycol-Maleimide (DOPE-PEG-Mal)is a linear heterobifunctional PEGylation reagent with an unsaturated DOPE phospholipid and maleimide group.DOPE-PEG-Mal is used to modify liposome surface with biomolecules containing thiol groups.It is a useful self-assembling reagent to prepare grafted or PEGylated liposome or micelle while also providing an amine group for bioconjugation.It is often used in targeted drug delivery with the lipid bilayer to improve drug solubility. | price> |
| R-M-1617 | LSKL, Inhibitor of Thrombospondin (TSP-1),CAS :283609-79-0 | This peptide, derived from the latency-associated peptide, inhibits thrombospondin (TSP-1) activation of TGF-beta; thus preventing the progression of hepatic damage and fibrosis. | price> |
| R-M-2098 | Amino-PEG4-Val-Cit-PAB-MMAE,Cas:1492056-71-9 | Amino-PEG4-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains an amino-PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. | price> |
| R-C-4134 | DOPE-polyethylene glycol550-MAL | 1,2-Dioleoyl-sn–glycero-3-phosphoethanolamine (DOPE)-polyethylene glycol-Maleimide (DOPE-PEG-Mal)is a linear heterobifunctional PEGylation reagent with an unsaturated DOPE phospholipid and maleimide group.DOPE-PEG-Mal is used to modify liposome surface with biomolecules containing thiol groups.It is a useful self-assembling reagent to prepare grafted or PEGylated liposome or micelle while also providing an amine group for bioconjugation.It is often used in targeted drug delivery with the lipid bilayer to improve drug solubility. | price> |
| R-M-1618 | MART-1 (26-35) (human),CAS :156251-01-3 | MART-1 (26-35), an immunodominant antigen from melanocyte/melanoma (Melan-A/MART) protein, is amino acid residue 26 to 35 of MART-1 protein. | price> |
| R-M-2099 | NHS ester-PEG4-Val-Cit-PAB-MMAE | NHS ester-PEG4-Val-Cit-PAB-MMAE can be used antibody drug conjugation as a precursor. It contains a PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PAB linker and an MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. | price> |
| R-C-4135 | Maleimide-PEG750-DOPE | 1,2-Dioleoyl-sn–glycero-3-phosphoethanolamine (DOPE)-polyethylene glycol-Maleimide (DOPE-PEG-Mal)is a linear heterobifunctional PEGylation reagent with an unsaturated DOPE phospholipid and maleimide group.DOPE-PEG-Mal is used to modify liposome surface with biomolecules containing thiol groups.It is a useful self-assembling reagent to prepare grafted or PEGylated liposome or micelle while also providing an amine group for bioconjugation.It is often used in targeted drug delivery with the lipid bilayer to improve drug solubility. | price> |
| R-M-1619 | MCDPeptide HR-1,CAS :80533-94-4 | MCD Peptide HR-1 is isolated from the venom of the giant hornet Vespa Orientalis and differs structurally from the MCD peptide from honeybee venom but possesses similar biological effects. These peptides are capable of degranulating rat mast cells, thereby initiating histamine release. | price> |
| R-M-3000 | Azido-PEG4-Val-Cit-PAB-MMAE,Cas:1869126-64-6 | Azido-PEG4-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains an azido-PEG4 spacer, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload.Azido enable click chemistry with alkyne-bearing moiety. | price> |
| R-C-4136 | DOPE-PEG350-NHS | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-NHS can be conjugated with peptides, antibodies, or proteins which contain Amine groups on the surface. | price> |
| R-M-1620 | Mating Factor alpha,CAS:59401-28-4 | Mating pheromone of mating type alpha cells of S. cerevisiae. This factor inhibits DNA synthesis, thereby preventing cell division of mating type a cells. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


